News
Alexion Clinical Trial
Alexion is now recruiting for copper and Molybdenum Balance in Participants with Wilson disease treated with ALXN 1840.
Click here for more information, or click here for a brochure about the trial.
Alexion is now recruiting for copper and Molybdenum Balance in Participants with Wilson disease treated with ALXN 1840.
Click here for more information, or click here for a brochure about the trial.